References
- Ajani JA, Mansfield PF, Crane CH, et al (2005). Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol, 23, 1237-44. https://doi.org/10.1200/JCO.2005.01.305
- Allum WH, Stenning SP, Bancewicz J, et al (2009). Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol, 27, 5062-67. https://doi.org/10.1200/JCO.2009.22.2083
- Ando N, Iizuka T, Ide H, et al (2003). Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol, 21, 4592-96. https://doi.org/10.1200/JCO.2003.12.095
- Archie V, Kauh J, Jones DV, et al (2006). Gastric cancer: standards for the 21st century. Crit Rev Oncol Hematol, 57, 123-31. https://doi.org/10.1016/j.critrevonc.2005.09.004
- Berger AC, Farma J, Scott WJ, et al (2005). Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol, 23, 4330-37. https://doi.org/10.1200/JCO.2005.05.017
- Cunningham D, Allum WH, Stenning SP, et al (2006). Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 355, 11-20. https://doi.org/10.1056/NEJMoa055531
- Dikken JL, van de Velde CJ, Coit DG, et al (2012). Treatment of resectable gastric cancer. Therap Adv Gastroenterol, 5, 49-69. https://doi.org/10.1177/1756283X11410771
- Flamant Y CJ, Huguier M, Quandalle P, et al (1999). Chimiotherapie adjuvante apres resection des adenocarcinomes gastriques: etude prospective controlee de l'effet de l'association 5FU, acide folinique et cisplatine. Gastroenterol Clin Biol, 21, 16.
- Gebski V, Burmeister B, Smithers BM, et al (2007). Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol, 8, 226-34. https://doi.org/10.1016/S1470-2045(07)70039-6
- Information on the Dutch CRITICS trial [Online]. Available: http://clinicaltrials.gov/ct2/show/NCT00407186 [Accessed 14 December 2010].
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Kelsen DP, Ginsberg R, Pajak TF, et al (1998). Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med, 339, 1979-84. https://doi.org/10.1056/NEJM199812313392704
- Law S, Fok M, Chow S, et al (1997). Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg, 114, 210-7. https://doi.org/10.1016/S0022-5223(97)70147-8
- Lee DJ, Sohn TS, Lim DH, et al (2012). Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer. Cancer Chemother Pharmacol, 69, 1333-38. https://doi.org/10.1007/s00280-012-1836-8
- Ott K, Lordick F, Blank S, et al (2011). Gastric cancer: surgery in 2011. Langenbecks Arch Surg, 396, 743-58. https://doi.org/10.1007/s00423-010-0738-7
- Pera M, Gallego R, Montagut C, et al (2012). Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer. Ann Oncol, 23, 664-70. https://doi.org/10.1093/annonc/mdr291
- Sadighi S, Raafat J, Mohagheghi M, et al (2005). Gastric carcinoma: 5 year experience of a single institute. Asian Pac J Cancer Prev, 6, 195-6.
- Shigeoka H, Imamoto H, Nishimura Y, et al (2010). Complete response to preoperative chemoradiotherapy in highly advanced gastric adenocarcinoma. World J Gastrointest Oncol, 2, 282-6. https://doi.org/10.4251/wjgo.v2.i6.282
- Urba SG, Orringer MB, Turrisi A, et al (2001). Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol, 19, 305-13. https://doi.org/10.1200/JCO.2001.19.2.305
- Urschel JD, Vasan H (2003). A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg, 185, 538-43. https://doi.org/10.1016/S0002-9610(03)00066-7
- Valenti V, Hernandez-Lizoain JL, Beorlegui MC, et al (2011). Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy. J Surg Oncol, 104, 124-9. https://doi.org/10.1002/jso.21947
- Weber WA, Ott K, Becker K, et al (2001). Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol, 19, 3058-65. https://doi.org/10.1200/JCO.2001.19.12.3058
- Working MRCOC (2002). Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet, 359, 1727-33. https://doi.org/10.1016/S0140-6736(02)08651-8
- Ychou M, Boige V, Pignon J-P, et al (2011). Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol, 29, 1715-21. https://doi.org/10.1200/JCO.2010.33.0597